Collegium Pharma Inc. (coll 2.875 02/15/29)
13F holders, Q2 2026 (June 30)1holders
1new positions
1sold out
$1.23avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Collegium Pharma Inc. (coll 2.875 02/15/29) in their 13F filings, unchanged from Q1 2026. 1 opened new positions and 1 sold out. The largest holder was Picton Mahoney Asset Management ($3.1M).
- Company
- Collegium Pharma Inc. (coll 2.875 02/15/29)
- CUSIP
- 19459JAC8
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $3.1M |
| Exits | 1 | $5.9M |
All 13F filers, Q1 2026 → Q2 2026: 2,500,000 shares bought and 5,100,000 shares sold, net −2,600,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Picton Mahoney Asset Management | 0.03% | New | 2,500,000 | $3.1M |
"% of holder's portfolio" is COLLEGIUM PHARMA INC (COLL 2.875 02/15/29)'s weight in each manager's 13F, not the share of Collegium Pharma Inc. (coll 2.875 02/15/29) the manager owns.